AB-1009

N/A

Report date: 2026/05/07 20:00:36

Base Information

Drug NameAB-1009
Drug Alias NameAB-1009
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHypotensionGlycogen Storage Disease Type II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAskBio Inc
China Registration ClassN/A

Develop Information

Active CompaniesAskBio IncBelief BioMed IncBayer AG
Inactive CompaniesN/A
Active IndicationsHypotensionGlycogen Storage Disease Type II
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A